DaVita Inc. shares soared after the kidney care provider posted robust fourth-quarter results and issued a 2026 profit forecast that significantly exceeded Wall Street expectations, signaling resilience against cost pressures and past operational challenges.
As financial institutions grow more complex, a new report warns that their greatest vulnerabilities often lie not in unknown threats, but in systemic blind spots where accountability is diffused across multiple committees and functions.
DaVita Inc. (NYSE: DVA) reported fourth-quarter revenue and profit that surpassed analyst forecasts, driven by strategic pricing and operational efficiency. The results sent shares sharply higher as the dialysis giant navigates a complex regulatory and demographic landscape.
Elon Musk is reportedly in advanced discussions to merge his space exploration giant, SpaceX, with his artificial intelligence venture, xAI, in a move that could reshape the frontiers of both industries and delay SpaceX's anticipated public offering.
Freshly released court documents include FBI testimony from a confidential source claiming the late financier Jeffrey Epstein managed hidden assets for Russian President Vladimir Putin and other powerful figures, shedding new light on his shadowy financial network.
While a seven-figure nest egg is a common retirement goal, financial experts caution that its sufficiency hinges on withdrawal strategies, lifestyle expectations, and supplemental income.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
A high-earning Orlando software engineer faces a stark choice: pursue a lifelong dream in federal law enforcement at a major pay cut and a significant real estate loss, or stay put in a lucrative tech career. His story highlights the personal costs behind shifting housing markets and career pivots.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
A historic winter storm has plunged American Airlines into its worst weather-related crisis, stranding crews and passengers while wiping up to $200 million from its revenue, exposing deep-seated recovery challenges.
Morgan Stanley's top strategist argues that recent U.S. trade shifts have prompted nations worldwide to reassess and leverage their own economic strengths, creating a multi-year investment opportunity in a more multipolar global order.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
CNBC's Jim Cramer highlighted International Business Machines Corp. (IBM) as a standout AI investment with a relatively modest valuation, following a robust quarterly report that sent shares soaring.
CNBC's Jim Cramer concedes he misjudged the explosive demand for Apple's iPhone 17, which powered the tech giant to a staggering earnings beat that caught Wall Street off guard.
Business Facilities magazine has named North Carolina its 'State of the Year' for business climate and economic development, the state's third such win in six years, following a surge of multi-billion dollar investments from tech and manufacturing giants.
A long-sealed financial document, signed by Jeffrey Epstein days before his death, details plans to bequeath his vast estate to a circle of associates, with his then-girlfriend Karyna Shuliak positioned to inherit $100 million and multiple properties in contemplation of marriage.
A 65-year-old Thai tourist was killed by a bull elephant with a known history of aggression in Khao Yai National Park, marking the animal's third human fatality and prompting urgent discussions on wildlife management strategies.
Despite both tech giants aggressively investing in AI, their stock prices are telling divergent stories. We examine the underlying fundamentals that make them resilient picks for any portfolio, regardless of short-term volatility.
Amid subscription fatigue and market fragmentation, the proposed union of Netflix and Warner Bros. Discovery is framed not as a threat to competition, but as a necessary consolidation to compete with tech giants and refocus value on consumers.
As the ASX braces for a turbulent February amid rate hike fears, a closer look reveals resilient micro-caps with unique value propositions. We analyze three sub-$150M companies—from healthcare tech to critical minerals—that are navigating the volatility with strong balance sheets and niche market positions.
